Page last updated: 2024-09-05

paris saponin vii and Bone Cancer

paris saponin vii has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bi, H; Cheng, G; Gao, F; Sun, X; Zhu, Y	1

Other Studies

1 other study(ies) available for paris saponin vii and Bone Cancer

Article	Year
Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway. Molecular medicine reports, 2016, Volume: 14, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Osteosarcoma; Saponins; Trillium	2016

Article

Year

Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway.

Molecular medicine reports, 2016, Volume: 14, Issue:4

Topics: Antineoplastic Agents, Phytogenic; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Osteosarcoma; Saponins; Trillium

2016